Cargando…

Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth

Aptamer-drug conjugates (ApDCs) have the potential to improve the therapeutic index of traditional chemotherapeutic agents due to their ability to deliver cytotoxic drugs specifically to cancer cells while sparing normal cells. This study reports on the conjugation of cytotoxic drugs to an aptamer p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Sorah, Huang, Kai-Wen, Reebye, Vikash, Spalding, Duncan, Przytycka, Teresa M., Wang, Yijie, Swiderski, Piotr, Li, Lin, Armstrong, Brian, Reccia, Isabella, Zacharoulis, Dimitris, Dimas, Konstantinos, Kusano, Tomokazu, Shively, John, Habib, Nagy, Rossi, John J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363417/ https://www.ncbi.nlm.nih.gov/pubmed/28325302 http://dx.doi.org/10.1016/j.omtn.2016.11.008

Ejemplares similares

Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo
por: Yoon, Sorah, et al.
Publicado: (2016)

Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
por: Yoon, Sorah, et al.
Publicado: (2019)

Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma
por: Kumar, Jayant, et al.
Publicado: (2018)

A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique
por: Jayant, Kumar, et al.
Publicado: (2018)

An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma
por: Yoon, Sorah, et al.
Publicado: (2018)

Impact of cavitron ultrasonic surgical aspirator (CUSA) and bipolar radiofrequency device (Habib-4X) based hepatectomy for hepatocellular carcinoma on tumour recurrence and disease-free survival
por: Huang, Kai-Wen, et al.
Publicado: (2017)

MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models
por: Huang, Kai-Wen, et al.
Publicado: (2021)

Aptamers: Uptake mechanisms and intracellular applications()
por: Yoon, Sorah, et al.
Publicado: (2018)

Case report on the role of radiofrequency-assisted spleen-preserving surgery for splenic metastasis in the era of check-point inhibitors
por: Mudan, Satwinder, et al.
Publicado: (2017)

Targeted Molecular Imaging Using Aptamers in Cancer
por: Yoon, Sorah, et al.
Publicado: (2018)

Antiviral nucleoside analogs
por: Kataev, Vladimir E., et al.
Publicado: (2021)

Nucleoside Analogs with Fleximer Nucleobase
por: Chudinov, Mikhail V.
Publicado: (2020)

Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant
por: Kumar, Jayant, et al.
Publicado: (2017)

Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)

Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer
por: Reebye, Vikash, et al.
Publicado: (2018)

Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile
por: Huang, Kai-Wen, et al.
Publicado: (2019)

New insights into the synergism of nucleoside analogs with radiotherapy
por: Lee, Michael W, et al.
Publicado: (2013)

Cannabinoids in the landscape of cancer
por: Mangal, Nagina, et al.
Publicado: (2021)

The nucleoside analog clitocine is a potent and efficacious readthrough agent
por: Friesen, Westley J., et al.
Publicado: (2017)

AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems
por: Wang, Yijie, et al.
Publicado: (2018)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
por: Borbone, Nicola, et al.
Publicado: (2021)

Diverse models for anti-HIV activity of purine nucleoside analogs
por: Khatri, Naveen, et al.
Publicado: (2015)

Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
por: Gmeiner, William H.
Publicado: (2019)

Synthesis of Sugar and Nucleoside Analogs and Evaluation of Their Anticancer and Analgesic Potentials
por: Hussain, Fahad, et al.
Publicado: (2022)

Nucleoside Analogs: A Review of Its Source and Separation Processes
por: Wang, Pan, et al.
Publicado: (2023)

Identification of Structural and Molecular Features Involved in the Transport of 3′-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
por: Rahman, MD Fazlur, et al.
Publicado: (2018)

Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in Borrelia burgdorferi
por: Chakraborti, Monideep, et al.
Publicado: (2020)

Structural Insights Into Tautomeric Dynamics in Nucleic Acids and in Antiviral Nucleoside Analogs
por: Fedeles, Bogdan I., et al.
Publicado: (2022)

Nucleoside analogs in ADAR guide strands targeting 5′-UA̲ sites
por: Brinkman, Hannah F., et al.
Publicado: (2022)

Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus
por: Dittmar, Mark, et al.
Publicado: (2023)

The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2
por: Feng, Joy Y., et al.
Publicado: (2022)

A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
por: Santos, Sean M., et al.
Publicado: (2019)

Efficient Synthesis of Purine Nucleoside Analogs by a New Trimeric Purine Nucleoside Phosphorylase from Aneurinibacillus migulanus AM007
por: Liu, Gaofei, et al.
Publicado: (2019)

Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term Outcomes
por: Kumar, J., et al.
Publicado: (2017)

Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer
por: Voutila, Jon, et al.
Publicado: (2017)

A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells
por: Reebye, Vikash, et al.
Publicado: (2013)

Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
por: Li, Yongshu, et al.
Publicado: (2022)

Computational studies on non-nucleoside analogs of pyrimidine as NNRTIs against HIV-1
por: Srivastava, Ritika, et al.
Publicado: (2014)

The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
por: Tsume, Yasuhiro, et al.
Publicado: (2014)

Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
por: Rechkoblit, Olga, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u8v0qsr8kj376fa4teg3lu388e